 Bailard Inc. bought a new stake in shares of Harpoon Therapeutics Inc NASDAQ:HARP in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission SEC. The fund bought 115,500 shares of the companys stock, valued at approximately 1,337,000. Bailard Inc. owned 0.46 of Harpoon Therapeutics at ... 